See more : Nightcap Plc (NGHT.L) Income Statement Analysis – Financial Results
Complete financial analysis of Treatment.Com International Inc. (TREIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Treatment.Com International Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Aimfinity Investment Corp. I (AIMAW) Income Statement Analysis – Financial Results
- Azarga Uranium Corp. (AZZ.TO) Income Statement Analysis – Financial Results
- FaithNetwork Co.,Ltd (3489.T) Income Statement Analysis – Financial Results
- Sunfun Info Co., Ltd. (5278.TWO) Income Statement Analysis – Financial Results
- Control Print Limited (CONTROLPR.BO) Income Statement Analysis – Financial Results
Treatment.Com International Inc. (TREIF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.treatment.com
About Treatment.Com International Inc.
Treatment.Com International Inc. provides personalized health care information services in Canada. It also develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. The company offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 377.28K | 656.40K | 326.85K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -377.28K | -656.40K | -326.85K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 354.49K | 590.20K | 2.19M | 1.30M | 326.02K | 20.55K | 31.96K |
| General & Administrative | 0.00 | 3.20M | 11.71M | 1.61M | 346.34K | 49.54K | 64.56K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.97M | 3.20M | 11.71M | 1.61M | 346.34K | 49.54K | 64.56K |
| Other Expenses | 0.00 | 0.00 | 9.83K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.33M | 3.79M | 13.90M | 2.91M | 672.36K | 70.08K | 96.52K |
| Cost & Expenses | 2.33M | 3.79M | 13.90M | 2.91M | 672.36K | 70.08K | 96.52K |
| Interest Income | 0.00 | 53.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 75.93K | 53.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 3.79M | 13.90M | 2.91M | 672.36K | 70.08K | 96.52K |
| EBITDA | -2.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.33M | -3.84M | -13.92M | -2.91M | -672.36K | -70.08K | -96.52K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.40M | 43.88K | 32.79K | 0.00 | -2.33M | 0.00 | 0.00 |
| Income Before Tax | -3.72M | -3.80M | -13.86M | -2.91M | -3.00M | -70.08K | -96.52K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -167.90K | -175.11K | -13.92M | -2.91M | 2.16M | -70.08K | -96.52K |
| Net Income | -3.72M | -3.80M | -13.86M | -2.91M | -3.00M | -70.08K | -96.52K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.26 | -0.57 | -2.14 | -0.45 | -0.47 | -0.01 | -0.02 |
| EPS Diluted | -0.26 | -0.57 | -2.14 | -0.45 | -0.47 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 14.35M | 6.62M | 6.48M | 6.40M | 6.40M | 6.40M | 6.40M |
| Weighted Avg Shares Out (Dil) | 14.35M | 6.62M | 6.48M | 6.40M | 6.40M | 6.40M | 6.40M |
Treatment.com AI Announces Contract Renewal with Leading US Medical School
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing...
Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor...
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment's proprietary...
Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity
VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that the Company has received funding from The National Institute of Health (“NIH”) to...
Treatment AI Passes Medical School Clinical Exam with 92% Success Rate
VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it's AI medical information support platform was used in the “Objective Structured Clinical...
TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT OF $2,908,200
Vancouver, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated February 16, 2024, it has closed a...
Treatment.com AI Provides Corporate Update
VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working diligently to continue its acceleration into...
TREATMENT.COM AI INC. APPOINTS CHIEF FINANCIAL OFFICER
Vancouver, BC, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce the appointment of Mr. David Worner as Chief Financial Officer of the Company, effective February...
CSE Bulletin: Consolidation - Treatment.com International Inc. (TRUE)
Toronto, Ontario--(Newsfile Corp. - Le 11 juillet/July 2023) - Treatment.com International Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As...
Source: https://incomestatements.info
Category: Stock Reports